Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and bloodDania Vázquez‐Blomquist, Gerardo Guillén, Iris Valdés et al.|Clinical Immunology Communications|2022Cited by 5
A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trialIdelsis Esquivel-Moynelo, Iraldo Bello Rivero, Jesus Perez-Escribano et al.|Annals of Antivirals and Antiretrovirals|2021Cited by 2